Nu Skin Enterprises Inc. (NUS) Options Positioning, Max Pain & Unusual Sweeps

Per the Roarable RQD rating, NUS scores 53 out of 100, grading D+ and carrying the verdict "Roarable Sell — Weak Fundamentals / Trim." The five pillars are: Fundamental Cash Engine at 6/20 (ROIC 6.7%; FCF yield 20.15%), Whale 13F Flow at 6/20 (institutional accumulation and options positioning), Insider Conviction at 15/20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 10/20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 16/20 (Altman Z 3.54; Piotroski F 7/9; Debt/Equity 0.25).

The weakest pillars are the cash engine and institutional flow, each at 6 of 20. The strongest relative pillar is the forensic balance sheet, supported by the Altman Z-Score of 3.54 and a Piotroski F-Score of 7 of 9. Insider conviction is the second-strongest pillar at 15 of 20. For a prospective investor, the upside case rests mainly on the balance sheet and the high FCF yield cited in the rating, which the rating's own cash engine pillar does not fully confirm given the low ROIC. The valuation tradeoff is that a 20.15% FCF yield on a $228.3M market capitalization sits alongside a 5.18% dividend yield, while the RQD rating assigns low marks to the cash engine and institutional flow. The rating's verdict signals that fundamentals are judged weak on the composite score. These are analytical observations drawn from the rating and are not personalized financial advice.

Per the SEC financials, revenue declined from $1969.1M in FY 2023 to $1485.2M in FY 2025, and FY 2025 net income of $160.2M compares with a net loss of $-146.6M in FY 2024. Per the market data, the gross margin is 69.4%, the operating margin 4.4%, and the net margin 10.8%. The ROIC is 6.7%. Per the Roarable RQD rating, the Altman Z-Score is 3.54 and the Piotroski F-Score is 7 of 9, with Debt/Equity at 0.25. Cash rose to $238.6M and debt fell to $204.2M in FY 2025 from $363.6M in FY 2024.

Per the news feed, the sources cover market action and institutional positioning for NUS. The headlines reference a forthcoming announcement of third quarter 2026 financial results, an upgrade at Zacks Research (flagged as a catalyst), and a projected earnings announcement on Thursday. Other items are market wire coverage of financial ratios and analyst ratings. The earnings-date and upgrade items are the most specific catalysts. The news items do not state their contents, figures, or the upgrade's rationale. Per the Butterfly Supply-Chain Graph, the supply chain is listed as NONE, with no butterfly links and no proprietary signals.

Per the Butterfly Supply-Chain Graph, the supply chain is NONE, with no upstream or downstream links, no sector correlations, and no proprietary signals recorded. Upstream and downstream dependencies, sector correlations, and second-order bottlenecks are not available in source data.

• What are the company's products, customers, and revenue drivers behind the decline from $1969.1M to $1485.2M in revenue?
• What drove the FY 2024 net loss of $-146.6M, and what returned the company to net income of $160.2M in FY 2025?
• What are the P/E, EV/EBITDA, and EPS figures that would allow valuation against the 20.15% FCF yield?
• What were the terms and drivers behind the Zacks Research upgrade referenced in the news feed?
• What are the FY 2023 cash and debt balances, which are not reported?